# MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer

> **NCT07514325** · NA · NOT_YET_RECRUITING · sponsor: **Radboud University Medical Center** · enrollment: 61 (estimated)

## Conditions studied

- Endometrial Cancer
- Radiotherapy, Adjuvant

## Interventions

- **RADIATION:** MR-guided adaptive radiotherapy (MGART) with reduced PTV margins, including 5 times 6Gy to the vaginal vault and pelvic nodal areas, 2 times a week

## Key facts

- **NCT ID:** NCT07514325
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2028-06-01
- **Final completion:** 2033-03-01
- **Target enrollment:** 61 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07514325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07514325, "MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07514325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*